Neuigkeiten im Kinderkrebsregister

Access to Specialized Paediatric Cancer Care in Switzerland

Martin Adam, Nicolas von der Weid, Gisela Michel, Marcel Zwahlen, Jean-Michel Lutz, Nicole Probst-Hensch, Felix Niggli, and Claudia Kuehni, for the Swiss Paediatric Oncology Group (SPOG){ and for the Swiss Association of Cancer Registries (ASRT)

Pediatric Blood and Cancer 2010;54(5):721–727

Specialized paediatric oncology care is thought to be essential to guarantee state-of-the-art treatment and hence maximal cure rates and minimal late effects for childhood and adolescent cancer patients. We compared data from the Swiss Childhood Cancer Registry and the 7 cantonal cancer registries including children diagnosed with cancer under age 16 years between 1990 and 2004. One in six childhood cancer patients (15.7%) had never been in specialized paediatric cancer care. This proportion was largest in children with malignant bone tumours, soft tissue sarcomas and malignant epithelial neoplasms. Of children aged 14 years and older 35% were not treated in specialized paediatric cancer care. However, the proportion of patients treated in specialized paediatric cancer care increased between 1990 and 2004 such that only 7% were not treated in specialised care in 2004. Currently it is unclear if specialized paediatric cancer care provides better care and treatment for all childhood cancer patients. However, the availability of a multidisciplinary team with psychologists and social workers in addition to paediatric oncologists and specialised nurses may especially help to improve late psycho-social outcomes.


© ISPM - Universität Bern 2019